Enterococcus faecalis infection and reactive oxygen species down-regulates the miR-17-92 cluster in gastric adenocarcinoma cell culture

Genes

Volumn 5, Issue 3, 2014, Pages 726-738

  Strickertsson, Jesper A B ^a   Rasmussen, Lene Juel ^a   Friis Hansen, Lennart ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

Author keywords

E. faecalis; Infection; MiR 17 92 cluster; MiRNA; Reactive oxygen species

Indexed keywords

MICRORNA; MICRORNA 106 363; MICRORNA 17 92; MICRORNA 24 2; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; POSIBACTERIA;

EID: 84923105694     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes5030726     Document Type: Article

References (46)

1. Ferlay, J.; Parkin, D.M.; Steliarova-Foucher, E. Estimates of cancer incidence and mortality in europe in 2008. Eur. J. Cancer 2010, 46, 765–781.
2. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69–90.
3. Hussain, S.P.; Harris, C.C. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer 2007, 121, 2373–2380.
4. Huang, J.Q.; Sridhar, S.; Chen, Y.; Hunt, R.H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology1998, 114, 1169–1179.
5. Amieva, M.R.; El-Omar, E.M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology2008, 134, 306–323.
6. Dicksved, J.; Lindberg, M.; Rosenquist, M.; Enroth, H.; Jansson, J.K.; Engstrand, L. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J. Med. Microbiol. 2009, 58, 509–516.
7. Fisher, K.; Phillips, C. The ecology, epidemiology and virulence of enterococcus. Microbiology2009, 155, 1749–1757.
8. Friis-Hansen, L.; Rieneck, K.; Nilsson, H.O.; Wadstrom, T.; Rehfeld, J.F. Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology2006, 131, 246–258.
9. Wang, X.; Allen, T.D.; May, R.J.; Lightfoot, S.; Houchen, C.W.; Huycke, M.M. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 2008, 68, 9909–9917.
10. Huycke, M.M.; Joyce, W.; Wack, M.F. Augmented production of extracellular superoxide by blood isolates of Enterococcus faecalis. J. Infect. Dis. 1996, 173, 743–746.
11. Strickertsson, J.A.; Desler, C.; Martin-Bertelsen, T.; Machado, A.M.; Wadstrom, T.; Winther, O.; Rasmussen, L.J.; Friis-Hansen, L. Enterococcus faecalis infection causes inflammation, intracellular oxphos-independent ros production, and DNA damage in human gastric cancer cells. PLoS One2013, 8, e63147.
12. Waris, G.; Ahsan, H. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5, doi:10.1186/1477-3163-5-14
13. Liou, G.Y.; Storz, P. Reactive oxygen species in cancer. Free Radic Res2010, 44, 479–496.
14. Ziech, D.; Franco, R.; Pappa, A.; Panayiotidis, M.I. Reactive oxygen species (ROS)—Induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011, 711, 167–173.
15. Kantner, H.P.; Warsch, W.; Delogu, A.; Bauer, E.; Esterbauer, H.; Casanova, E.; Sexl, V.; Stoiber, D. ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells. Neoplasia2013, 15, 1292–1300.
16. Yang, Y.; Karakhanova, S.; Werner, J.; Bazhin, A.V. Reactive oxygen species in cancer biology and anticancer therapy. Curr. Med. Chem. 2013, 20, 3677–3692.
17. Jutooru, I.; Guthrie, A.S.; Chadalapaka, G.; Pathi, S.; Kim, K.; Burghardt, R.; Jin, U.H.; Safe, S. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Mol. Cell. Biol. 2014, 34, 2382–2395.
18. Chadalapaka, G.; Jutooru, I.; Safe, S. Celastrol decreases specificity proteins (SP) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells. Carcinogenesis2012, 33, 886–894.
19. Di Leva, G.; Croce, C.M. Roles of small RNAs in tumor formation. Trends Mol. Med.2010, 16, 257–267.
20. Volinia, S.; Calin, G.A.; Liu, C.G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; et al.A microrna expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA2006, 103, 2257–2261.
21. Ueda, T.; Volinia, S.; Okumura, H.; Shimizu, M.; Taccioli, C.; Rossi, S.; Alder, H.; Liu, C.G.; Oue, N.; Yasui, W.; et al.Relation between microrna expression and progression and prognosis of gastric cancer: A microrna expression analysis. Lancet Oncol. 2010, 11, 136–146.
22. Guo, J.; Miao, Y.; Xiao, B.; Huan, R.; Jiang, Z.; Meng, D.; Wang, Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol. 2009, 24, 652–657.
23. Wu, W.K.; Lee, C.W.; Cho, C.H.; Fan, D.; Wu, K.; Yu, J.; Sung, J.J. microRNA dysregulation in gastric cancer: A new player enters the game. Oncogene 2010, 29, 5761–5771.
24. Bartel, D.P. microRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281–297.
25. Kim, V.N.; Han, J.; Siomi, M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol.2009, 10, 126–139.
26. Wan, G.; Liu, Y.; Han, C.; Zhang, X.; Lu, X. Noncoding RNAs in DNA repair and genome integrity. Antioxid. Redox Signal. 2014, 20, 655–677.
27. Cho, W.C. Micrornas in cancer—From research to therapy. Biochim. Biophys. Acta2010, 1805, 209–217.
28. Cho, W.C. microRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 2010, 42, 1273–1281.
29. Xiang, J.; Wu, J. Feud or friend? The role of the miR-17-92 cluster in tumorigenesis. Curr. Genomics2010, 11, 129–135.
30. Mogilyansky, E.; Rigoutsos, I. The miR-17/92 cluster: A comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013, 20, 1603–1614.
31. Shrestha, S.; Hsu, S.D.; Huang, W.Y.; Huang, H.Y.; Chen, W.; Weng, S.L.; Huang, H.D. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 2014, 3, 878–888
32. Genechip®Command Console® Software 3.0 Version; Affymetrix, Inc.: Santa Clara, CA, USA, 2009.
33. Schmittgen, T.D.; Livak, K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3, 1101–1108.
34. Thulasingam, S.; Massilamany, C.; Gangaplara, A.; Dai, H.; Yarbaeva, S.; Subramaniam, S.; Riethoven, J.J.; Eudy, J.; Lou, M.; Reddy, J. miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kb pathway in raw 264.7 cells. Mol. Cell. Biochem.2011, 352, 181–188.
35. Ebi, H.; Sato, T.; Sugito, N.; Hosono, Y.; Yatabe, Y.; Matsuyama, Y.; Yamaguchi, T.; Osada, H.; Suzuki, M.; Takahashi, T. Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene2009, 28, 3371–3379.
36. Yan, H.L.; Xue, G.; Mei, Q.; Wang, Y.Z.; Ding, F.X.; Liu, M.F.; Lu, M.H.; Tang, Y.; Yu, H.Y.; Sun, S.H. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 2009, 28, 2719–2732.
37. Grillari, J.; Hackl, M.; Grillari-Voglauer, R. miR-17-92 cluster: Ups and downs in cancer and aging. Biogerontology2010, 11, 501–506.
38. Strickertsson, J.A.; Desler, C.; Rasmussen, L.J. Impact of bacterial infections on aging and cancer: Impairment of DNA repair and mitochondrial function of host cells. Exp. Gerontol.2014, doi:10.1016/j.exger.2014.03.024.
39. Handa, O.; Naito, Y.; Yoshikawa, T. Helicobacter pylori: A ros-inducing bacterial species in the stomach. Inflamm Res. 2010, 59, 997–1003.
40. Pathi, S.S.; Jutooru, I.; Chadalapaka, G.; Sreevalsan, S.; Anand, S.; Thatcher, G.R.; Safe, S. Gt-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol. Cancer Res. 2011, 9, 195–202.
41. Wu, W.; Takanashi, M.; Borjigin, N.; Ohno, S.I.; Fujita, K.; Hoshino, S.; Osaka, Y.; Tsuchida, A.; Kuroda, M. microRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br. J. Cancer 2013, 108, 653–661.
42. Wang, F.; Li, T.; Zhang, B.; Li, H.; Wu, Q.; Yang, L.; Nie, Y.; Wu, K.; Shi, Y.; Fan, D. microRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting pten. Biochem. Biophys. Res. Commun. 2013, 434, 688–694.
43. Li, X.; Zhang, Z.; Yu, M.; Li, L.; Du, G.; Xiao, W.; Yang, H. Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int. J. Mol. Sci. 2013, 14, 16226–16239.
44. Yu, Z.; Wang, C.; Wang, M.; Li, Z.; Casimiro, M.C.; Liu, M.; Wu, K.; Whittle, J.; Ju, X.; Hyslop, T.; et al.A cyclin D1/microrna 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008, 182, 509–517.
45. Zhang, G.; Zhou, H.; Xiao, H.; Liu, Z.; Tian, H.; Zhou, T. microRNA-92a functions as an oncogene in colorectal cancer by targeting pten. Dig. Dis. Sci. 2014, 59, 98–107.
46. Machado, A.M.; Figueiredo, C.; Touati, E.; Maximo, V.; Sousa, S.; Michel, V.; Carneiro, F.; Nielsen, F.C.; Seruca, R.; Rasmussen, L.J. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin. Cancer Res. 2009, 15, 2995–3002.